» Articles » PMID: 39886919

Role of Hepatocyte RIPK1 in Maintaining Liver Homeostasis During Metabolic Challenges

Overview
Journal Elife
Date 2025 Jan 31
PMID 39886919
Authors
Affiliations
Soon will be listed here.
Abstract

As a central hub for metabolism, the liver exhibits strong adaptability to maintain homeostasis in response to food fluctuations throughout evolution. However, the mechanisms governing this resilience remain incompletely understood. In this study, we identified Receptor interacting protein kinase 1 (RIPK1) in hepatocytes as a critical regulator in preserving hepatic homeostasis during metabolic challenges, such as short-term fasting or high-fat dieting. Our results demonstrated that hepatocyte-specific deficiency of RIPK1 sensitized the liver to short-term fasting-induced liver injury and hepatocyte apoptosis in both male and female mice. Despite being a common physiological stressor that typically does not induce liver inflammation, short-term fasting triggered hepatic inflammation and compensatory proliferation in hepatocyte-specific RIPK1-deficient (-hepKO) mice. Transcriptomic analysis revealed that short-term fasting oriented the hepatic microenvironment into an inflammatory state in -hepKO mice, with up-regulated expression of inflammation and immune cell recruitment-associated genes. Single-cell RNA sequencing further confirmed the altered cellular composition in the liver of -hepKO mice during fasting, highlighting the increased recruitment of macrophages to the liver. Mechanically, our results indicated that ER stress was involved in fasting-induced liver injury in -hepKO mice. Overall, our findings revealed the role of RIPK1 in maintaining liver homeostasis during metabolic fluctuations and shed light on the intricate interplay between cell death, inflammation, and metabolism.

Citing Articles

Role of hepatocyte RIPK1 in maintaining liver homeostasis during metabolic challenges.

Zhang W, Liu H, Zhang D, Yi Y, Tao L, Zhu Y Elife. 2025; 13.

PMID: 39886919 PMC: 11785375. DOI: 10.7554/eLife.96798.

References
1.
Xu G, Li Y, Zhang S, Peng H, Wang Y, Li D . SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation. Cell Res. 2021; 31(12):1230-1243. PMC: 8522117. DOI: 10.1038/s41422-021-00578-7. View

2.
Jin S, Guerrero-Juarez C, Zhang L, Chang I, Ramos R, Kuan C . Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021; 12(1):1088. PMC: 7889871. DOI: 10.1038/s41467-021-21246-9. View

3.
Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, De Vos R . Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell. 2007; 11(2):119-32. DOI: 10.1016/j.ccr.2006.12.016. View

4.
Imanishi T, Unno M, Yoneda N, Motomura Y, Mochizuki M, Sasaki T . RIPK1 blocks T cell senescence mediated by RIPK3 and caspase-8. Sci Adv. 2023; 9(4):eadd6097. PMC: 9876550. DOI: 10.1126/sciadv.add6097. View

5.
Cotter D, Ercal B, dAvignon D, Dietzen D, Crawford P . Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice. Am J Physiol Endocrinol Metab. 2014; 307(2):E176-85. PMC: 4101633. DOI: 10.1152/ajpendo.00087.2014. View